Article
Combined platelet count with sCD163 and genetic variants optimizes esophageal varices prediction in cirrhotic patients.
Journal of gastroenterology and hepatology - 1 Jan 2013
Yang Ying-Ying, Hou Ming-Chih, Lin Ming-Wei, Chen Ping-Hsien, Liao Wei-Chih, Chu Chi-Jen, Lin Han-Chieh
Abstract excerpt
BACKGROUND AND AIM: Endoscopic screening for esophageal varices (EVs) is expensive and invasive. Besides traditional noninvasive markers, we explore additional candidate markers including portal hypertension serum marker-soluble CD136 (sCD163) and genetic variants of splanchnic vasodilatation and revascularization pathways for prediction of EVs in cirrhotic patients. METHODS: A total of 951 cirrhotic patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
